Nautilus Biotechnology, INC DEF 14A proxy statements
Proxy statements, covering the matters put to shareholders at the annual meeting — board elections, auditor ratification and executive pay.
NASDAQ
Nautilus Biotechnology, Inc. has issued its definitive proxy statement, announcing its 2026 Annual Meeting of Stockholders to be held virtually on June 17, 2026, detailing proposals for director elections, auditor ratification, and executive compensation.
NASDAQ
Nautilus Biotechnology announces its 2025 Annual Meeting of Stockholders to be held virtually on June 20, 2025, outlining key voting items including the election of directors and ratification of the company's accounting firm.
NASDAQ
Nautilus Biotechnology is set to hold its annual stockholder meeting on June 20, 2025, to elect directors and ratify the appointment of PricewaterhouseCoopers LLP as its independent accounting firm.
NASDAQ
Nautilus Biotechnology has scheduled its 2024 Annual Meeting for June 13, 2024, and is providing proxy materials to stockholders for voting on key proposals.
NASDAQ
Nautilus Biotechnology announces its annual meeting of stockholders to be held virtually on June 13, 2024, to elect directors and ratify the appointment of its independent accounting firm.